Panobinostat shows efficacy in Hodgkin lymphoma
- PMID: 22684466
- DOI: 10.1158/2159-8290.CD-RW2012-064
Panobinostat shows efficacy in Hodgkin lymphoma
Abstract
Panobinostat monotherapy is active against relapsed or refractory Hodgkin lymphoma.
Comment on
-
Panobinostat in patients with relapsed/refractory Hodgkin's lymphoma after autologous stem-cell transplantation: results of a phase II study.J Clin Oncol. 2012 Jun 20;30(18):2197-203. doi: 10.1200/JCO.2011.38.1350. Epub 2012 Apr 30. J Clin Oncol. 2012. PMID: 22547596 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
